Poster
# 10

Main Page

6th Internet World Congress for Biomedical Sciences

IndexIndex
Multi-page version
Dynamic pages

BREAST SCINTIMAMMOGRAPHY WITH MIBI-Tc99m AS A PREDICTOR OF TUMORAL AGGRESSIVENESS.

Francisca Mulero(1), V. Roca(2), F. Nicolás(3), Francisca Mulero(4), J.A. Nuño de la Rosa(5)
(1)(4)(5)Hospital Universitario Virgen de la Arrixaca - San Miguel de Salinas. Spain
(2)(3)Servicio de Medicina Nuclear. Hospital Universitario Virgen de la Arrixaca (Murcia) - Murcia. Spain

[ABSTRACT] [INTRODUCTION] [MATERIALS & METHODS] [RESULTS] [FIGURES] [CONCLUSIONS] [Discussion Board]
ABSTRACT Previous: Cholesterol Granuloma (Cholesteroloma) Of The Mammary Gland MATERIALS & METHODS
[Oncology]
Next: Inorganic cobalt(III) complexes with Schiff bases as a new anticancer agents with radio/thermosensitizing activities
[Radiology & Nuclear Medicine]
Next: Active contours and medical imaging

INTRODUCTION Top Page

MIBI-Tc99m is a tumor-seeking agent used in diagnosis of breast carcinomas. The mechanism by which it concentrates in the malignant tissue is unknown. Certain breast tumors do not show MIBI-Tc99m uptake. False negatives and false positives DO EXISTS!

The aim of our study was to determine the correlation between MIBI -Tc99m uptake and histopathological parameters of breast tumor aggressiveness.

MATERIALS & METHODS Top Page

Patients: 84 female patients with diagnosed breast carcinoma (52.1 ± 12.7)(age 22-81 years). All patients were scheduled for radical surgery.

Method: 99mTc-MIBI imaging according to the protocol in our institution: 740-925 MBq (Cardiolite® from DuPont Pharma) injected EV in an antecubital vein contralateral to the breast undergoing evaluation.

  • Planar images. 256 x 256 pixels (0.2210 cm/pixel) in a single head gammacamera with LEHR collimator. 10% window centered at Technetium´s photopeak. Prone position. Special positioning device. Imaging 5 and 90 minutes after injection for 10 minutes or 1,500 kcts.

99mTc-MIBI semiquantitative analysis:

  • ROI drawn over the uptake area. Total counts divided into the number of pixels yielded a mean value per pixel (T). A similar ROI over background activity was B value.

  • Tumor-to-background uptake ratio (T/B) was calculated in all patients.

  • Early (5 minutes) and delayed (1 hour) (E/D) difference in uptake was calculated with the formula:

E/D=log n early T/B - log n delayed T/B

  • Histopathological study:

    • Tumor size.

    • Presence or absence of axillar lymph node metastases.

    • Histological Degree (Scarff Bloom Richardson).

    • Nuclear Degree.

    • Mitotic Index.

    • Cellular Atypia.

    • Oestrogen receptor expression.

Statistical Analysis: The significance of proportions was evaluated by Fisher´s exact test. Comparison of MIBI uptake with different prognostic factors was made with ANOVA test and mean comparisons with a t-Student test.

RESULTS Top Page

There are a statistically significant correlation with:

  • Mitotic index. The higher the mitotic index is, the higher the T/B ratio and the lower early/delayed difference (washout decreases).

  • Negative correlation with SCBR histological degree. The less differentiated the more intense the uptake is with higher T/B ratio and lower washout index.

 

*p = 0.02

**p = 0.05

Mitotic Index

Scarff Bloom Richardson grade

 

Low

Mild

High

I

II

III

Early lat T/B ratio*

1.91 ± 0.4

 

2.15 ± 0.6

2.51 ± 0.9

2.08 ± 0.6

2.14 ± 0.5

2.33 ± 0.9

Ant T/B ratio*

1.61 ± 0.4

1.74 ± 0.4

2.05 ± 0.9

1.68 ± 0.3

1.69 ± 0.5

1.99 ± 0.02

D T/B ratio*

1.66 ± 0.5

1.88 ± 0.4

2.45 ± 0.9

1.64 ± 0.5

1.87 ± 0.6

2.29 ± 0.9

E/D **

0.14 ± 0.2

0.06 ± 0.1

0.09 ± 0.09

0.19 ± 0.2

0.09 ± 0.1

0.02 ± 0.09

CONCLUSIONS Top Page

  • MIBI-Tc99m uptake in breast carcinoma significantly correlates with differentiation degree: The less differentiated the higher uptake.

  • We found no correlation with the main histological parameters that define tumoral aggressiveness (tumor size, oestrogen receptor expression or axillar lymph node metastases).


Discussion Board
Discussion Board

Any Comment to this presentation?

[ABSTRACT] [INTRODUCTION] [MATERIALS & METHODS] [RESULTS] [FIGURES] [CONCLUSIONS] [Discussion Board]

ABSTRACT Previous: Cholesterol Granuloma (Cholesteroloma) Of The Mammary Gland MATERIALS & METHODS
[Oncology]
Next: Inorganic cobalt(III) complexes with Schiff bases as a new anticancer agents with radio/thermosensitizing activities
[Radiology & Nuclear Medicine]
Next: Active contours and medical imaging
Francisca Mulero, V. Roca, F. Nicolás, Francisca Mulero, J.A. Nuño de la Rosa
Copyright © 1999-2000. All rights reserved.
Last update: 16/01/00